This is the authors' abstract. We don't add key points for this paper.
A novel 3D luminescent metal–organic framework (MOF) denoted as [Eu(BTA) 0.5 (H 2 BTA) 0.5 (H 2 O)] n (Cj-2) has been constructed from a π-conjugated ligand with a tetracarboxylate group, 1,2,4,5-benzenetetracarboxylic acid (BTA), via solvothermal synthesis.
No takes yet. Share an insight, caveat, or question.
Sen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: